Mobile

Study of EGF816 in combination with Nivolumab in adult patients with EGFR mutated non-small cell lung cancer and of INC280 in combination with Nivolumab in adult patients with cMet positive non-small ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003731-20

Study of EGF816 in combination with Nivolumab in adult patients with EGFR mutated non-small cell lung cancer and of INC280 in combination with Nivolumab in adult patients with cMet positive non-small cell lung cancer

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To estimate the clinical activity of Nivolumab in combination with EGF816 or INC280

Critère d'inclusion

  • EGFR mutated non-small cell lung cancer and EGFR wild-type non-small cell lung cancer

Liens